Galapagos is a dynamic and growing biotechnology company headquartered in Mechelen, Belgium, with offices across Europe and the US. The company is dedicated to addressing high unmet medical needs by leveraging innovative science and technology to develop a robust pipeline of best-in-class small molecules, CAR-T therapies, and biologics, particularly in oncology and immunology. Galapagos is committed to transforming patient lives through collaborative approaches and a decentralized CAR-T manufacturing network. The company fosters a culture of empowerment and continuous growth, prioritizing the well-being of its employees while striving to make a significant impact on the healthcare industry and the planet.